A randomized trial of epinephrine in out-of-hospital cardiac arrest
BACKGROUND:Concern about the use of epinephrine as a treatment for out-of-hospital cardiac arrest led the International Liaison Committee on Resuscitation to call for a placebo-controlled trial to determine whether the use of epinephrine is safe and effective in such patients. METHODS:In a randomize...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Outros autores: | |
| Formato: | Journal article |
| Idioma: | English |
| Publicado: |
Massachusetts Medical Society
2018
|
| _version_ | 1826279686982860800 |
|---|---|
| author | Perkins, GD Ji, C Deakin, CD Quinn, T Nolan, JP Scomparin, C Regan, S Long, J Slowther, A Pocock, H Black, JJM Moore, F Fothergill, RT Rees, N O'Shea, L Docherty, M Gunson, I Han, K Charlton, K Finn, J Petrou, S Stallard, N Gates, S Lall, R |
| author2 | Paramedic2 Collaborators, |
| author_facet | Paramedic2 Collaborators, Perkins, GD Ji, C Deakin, CD Quinn, T Nolan, JP Scomparin, C Regan, S Long, J Slowther, A Pocock, H Black, JJM Moore, F Fothergill, RT Rees, N O'Shea, L Docherty, M Gunson, I Han, K Charlton, K Finn, J Petrou, S Stallard, N Gates, S Lall, R |
| author_sort | Perkins, GD |
| collection | OXFORD |
| description | BACKGROUND:Concern about the use of epinephrine as a treatment for out-of-hospital cardiac arrest led the International Liaison Committee on Resuscitation to call for a placebo-controlled trial to determine whether the use of epinephrine is safe and effective in such patients. METHODS:In a randomized, double-blind trial involving 8014 patients with out-of-hospital cardiac arrest in the United Kingdom, paramedics at five National Health Service ambulance services administered either parenteral epinephrine (4015 patients) or saline placebo (3999 patients), along with standard care. The primary outcome was the rate of survival at 30 days. Secondary outcomes included the rate of survival until hospital discharge with a favorable neurologic outcome, as indicated by a score of 3 or less on the modified Rankin scale (which ranges from 0 [no symptoms] to 6 [death]). RESULTS:At 30 days, 130 patients (3.2%) in the epinephrine group and 94 (2.4%) in the placebo group were alive (unadjusted odds ratio for survival, 1.39; 95% confidence interval [CI], 1.06 to 1.82; P=0.02). There was no evidence of a significant difference in the proportion of patients who survived until hospital discharge with a favorable neurologic outcome (87 of 4007 patients [2.2%] vs. 74 of 3994 patients [1.9%]; unadjusted odds ratio, 1.18; 95% CI, 0.86 to 1.61). At the time of hospital discharge, severe neurologic impairment (a score of 4 or 5 on the modified Rankin scale) had occurred in more of the survivors in the epinephrine group than in the placebo group (39 of 126 patients [31.0%] vs. 16 of 90 patients [17.8%]). CONCLUSIONS:In adults with out-of-hospital cardiac arrest, the use of epinephrine resulted in a significantly higher rate of 30-day survival than the use of placebo, but there was no significant between-group difference in the rate of a favorable neurologic outcome because more survivors had severe neurologic impairment in the epinephrine group. (Funded by the U.K. National Institute for Health Research and others; Current Controlled Trials number, ISRCTN73485024 .). |
| first_indexed | 2024-03-07T00:02:29Z |
| format | Journal article |
| id | oxford-uuid:766feb51-d52a-48be-a9a8-ff726f4335f4 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:02:29Z |
| publishDate | 2018 |
| publisher | Massachusetts Medical Society |
| record_format | dspace |
| spelling | oxford-uuid:766feb51-d52a-48be-a9a8-ff726f4335f42022-03-26T20:16:20ZA randomized trial of epinephrine in out-of-hospital cardiac arrestJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:766feb51-d52a-48be-a9a8-ff726f4335f4EnglishSymplectic Elements at OxfordMassachusetts Medical Society2018Perkins, GDJi, CDeakin, CDQuinn, TNolan, JPScomparin, CRegan, SLong, JSlowther, APocock, HBlack, JJMMoore, FFothergill, RTRees, NO'Shea, LDocherty, MGunson, IHan, KCharlton, KFinn, JPetrou, SStallard, NGates, SLall, RParamedic2 Collaborators,BACKGROUND:Concern about the use of epinephrine as a treatment for out-of-hospital cardiac arrest led the International Liaison Committee on Resuscitation to call for a placebo-controlled trial to determine whether the use of epinephrine is safe and effective in such patients. METHODS:In a randomized, double-blind trial involving 8014 patients with out-of-hospital cardiac arrest in the United Kingdom, paramedics at five National Health Service ambulance services administered either parenteral epinephrine (4015 patients) or saline placebo (3999 patients), along with standard care. The primary outcome was the rate of survival at 30 days. Secondary outcomes included the rate of survival until hospital discharge with a favorable neurologic outcome, as indicated by a score of 3 or less on the modified Rankin scale (which ranges from 0 [no symptoms] to 6 [death]). RESULTS:At 30 days, 130 patients (3.2%) in the epinephrine group and 94 (2.4%) in the placebo group were alive (unadjusted odds ratio for survival, 1.39; 95% confidence interval [CI], 1.06 to 1.82; P=0.02). There was no evidence of a significant difference in the proportion of patients who survived until hospital discharge with a favorable neurologic outcome (87 of 4007 patients [2.2%] vs. 74 of 3994 patients [1.9%]; unadjusted odds ratio, 1.18; 95% CI, 0.86 to 1.61). At the time of hospital discharge, severe neurologic impairment (a score of 4 or 5 on the modified Rankin scale) had occurred in more of the survivors in the epinephrine group than in the placebo group (39 of 126 patients [31.0%] vs. 16 of 90 patients [17.8%]). CONCLUSIONS:In adults with out-of-hospital cardiac arrest, the use of epinephrine resulted in a significantly higher rate of 30-day survival than the use of placebo, but there was no significant between-group difference in the rate of a favorable neurologic outcome because more survivors had severe neurologic impairment in the epinephrine group. (Funded by the U.K. National Institute for Health Research and others; Current Controlled Trials number, ISRCTN73485024 .). |
| spellingShingle | Perkins, GD Ji, C Deakin, CD Quinn, T Nolan, JP Scomparin, C Regan, S Long, J Slowther, A Pocock, H Black, JJM Moore, F Fothergill, RT Rees, N O'Shea, L Docherty, M Gunson, I Han, K Charlton, K Finn, J Petrou, S Stallard, N Gates, S Lall, R A randomized trial of epinephrine in out-of-hospital cardiac arrest |
| title | A randomized trial of epinephrine in out-of-hospital cardiac arrest |
| title_full | A randomized trial of epinephrine in out-of-hospital cardiac arrest |
| title_fullStr | A randomized trial of epinephrine in out-of-hospital cardiac arrest |
| title_full_unstemmed | A randomized trial of epinephrine in out-of-hospital cardiac arrest |
| title_short | A randomized trial of epinephrine in out-of-hospital cardiac arrest |
| title_sort | randomized trial of epinephrine in out of hospital cardiac arrest |
| work_keys_str_mv | AT perkinsgd arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT jic arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT deakincd arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT quinnt arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT nolanjp arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT scomparinc arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT regans arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT longj arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT slowthera arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT pocockh arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT blackjjm arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT mooref arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT fothergillrt arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT reesn arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT osheal arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT dochertym arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT gunsoni arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT hank arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT charltonk arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT finnj arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT petrous arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT stallardn arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT gatess arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT lallr arandomizedtrialofepinephrineinoutofhospitalcardiacarrest AT perkinsgd randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT jic randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT deakincd randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT quinnt randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT nolanjp randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT scomparinc randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT regans randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT longj randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT slowthera randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT pocockh randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT blackjjm randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT mooref randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT fothergillrt randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT reesn randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT osheal randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT dochertym randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT gunsoni randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT hank randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT charltonk randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT finnj randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT petrous randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT stallardn randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT gatess randomizedtrialofepinephrineinoutofhospitalcardiacarrest AT lallr randomizedtrialofepinephrineinoutofhospitalcardiacarrest |